|
Volumn 8, Issue 2, 2008, Pages 124-133
|
Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancer
|
Author keywords
Aromatase inhibitors; Diethylstilbestrol; Fulvestrant; Medroxyprogesterone acetate; Raloxifene
|
Indexed keywords
ANASTROZOLE;
AROMATASE INHIBITOR;
CLOMIFENE;
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
DIETHYLSTILBESTROL;
EQUILENIN;
EQUILIN;
ESTRADIOL;
ESTROGEN;
ESTROGEN RECEPTOR;
ESTRONE SULFATE;
FULVESTRANT;
PROGESTERONE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
TAMOXIFEN CITRATE;
APOPTOSIS;
BREAST CANCER;
CANCER GROWTH;
CANCER RESISTANCE;
CANCER SURVIVAL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG STRUCTURE;
DRUG WITHDRAWAL;
EDEMA;
HOMEOSTASIS;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
LONG TERM CARE;
METASTASIS;
NAUSEA;
OSTEOPOROSIS;
POSTMENOPAUSE;
REVIEW;
STRUCTURE ACTIVITY RELATION;
VAGINA BLEEDING;
VOMITING;
|
EID: 43249097005
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.3816/CBC.2008.n.012 Document Type: Review |
Times cited : (23)
|
References (96)
|